Marinomed Biotech AG | WebDisclosure

Basculer en Français

10368	Companies
215969	Keywords
145712	Articles
114376	Press releases

Home
Companies
Marinomed Biotech AG

PRESS RELEASE

published on 08/14/2024 at 09:17, 1 year 8 months ago

Marinomed Biotech AG aims for financial reorganization by restructuring proceedings without self-administration
Marinomed Biotech AG to undergo financial reorganization through restructuring proceedings without self-administration. Application filed as liquidity needs could not be met promptly

Liquidity Insolvency Marinomed Biotech AG Financial Reorganization Restructuring Proceedings
BRIEF

published on 08/13/2024 at 23:09, 1 year 8 months ago

Marinomed Biotech AG Applies for Court Restructuring Proceedings

Restructuring Insolvency Carragelose Financial Stability Marinomed
BRIEF

published on 08/13/2024 at 23:09, 1 year 8 months ago

Marinomed Biotech AG demande une procédure de restructuration devant le tribunal

Restructuration Insolvabilité Stabilité Financière Marinomé Carraghénose
PRESS RELEASE

published on 08/13/2024 at 23:04, 1 year 8 months ago

EQS-Adhoc: Marinomed Biotech AG applies for court restructuring proceedings without self-administration
Marinomed Biotech AG applies for court restructuring proceedings without self-administration to ensure financial stability amid imminent insolvency

Insolvency Marinomed Biotech AG Financial Stability Restructuring Plan Court Restructuring Proceedings
BRIEF

published on 06/14/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG Secures Licensing Agreement for Carragelose® Distribution in Europe

Licensing Agreement Distribution Marinomed Biotech Carragelose® Consumer Health Care
BRIEF

published on 06/14/2024 at 07:50, 1 year 10 months ago

Marinomed Biotech AG conclut un accord de licence pour la distribution du Carragelose® en Europe

Distribution Marinomed Biotech Accord De Licence Carragelose® Soins De Santé Grand Public
PRESS RELEASE

published on 06/14/2024 at 07:45, 1 year 10 months ago

Marinomed Biotech AG secures licensure with leading Consumer Health Care player for the distribution of Carragelose® products in Europe
Marinomed Biotech AG expands licensing agreement with leading Consumer Health Care player for Carragelose® product distribution in Europe, enabling milestone payments

Marinomed Biotech AG Distribution Carragelose® Consumer Health Care Licensure
BRIEF

published on 05/22/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG Reports Q1 2024 Financial Results

Financial Performance Biotech Partnerships Q1 2024 Results Marinomed
BRIEF

published on 05/22/2024 at 07:50, 1 year 11 months ago

Marinomed Biotech AG publie ses résultats financiers du premier trimestre 2024

Performance Financière Partenariats Marinomé Résultats Du Premier Trimestre 2024 Biotechnologies
PRESS RELEASE

published on 05/22/2024 at 07:45, 1 year 11 months ago

Marinomed Biotech AG announces results for the first quarter of 2024
Marinomed Biotech AG announces results for Q1 2024 with declining revenues to pre-pandemic levels. New partnerships, agreements, and initiatives in place to boost cash flows and cover financing needs

Partnerships Marinomed Biotech AG Q1 2024 Results Revenues Decline Cash Flow Initiatives

Accesswire

Published on 05/08/2026 at 01:50, 2 hours 27 minutes ago

Apex Critical Metals Announces Grant of Stock Options and RSUs
Published on 05/08/2026 at 00:45, 3 hours 32 minutes ago

Route1 Announces First Quarter 2026 Financial Results Notification
Published on 05/08/2026 at 00:00, 4 hours 17 minutes ago

Redwood AI Approved to Receive National Research Council of Canada Funding for its Q-SAFE Chemical Screening Project for Defence and Security Applications
Published on 05/07/2026 at 23:30, 4 hours 47 minutes ago

Faraday Copper Reports First Quarter 2026 Financial Results
Published on 05/07/2026 at 23:15, 5 hours 2 minutes ago

BULGOLD Adopts Semi-Annual Financial Reporting

View all ACCESSWIRE

EQS Group

Published on 05/07/2026 at 23:23, 4 hours 53 minutes ago

H1 25/26: Challenging environment and significant changes in IT market // Revised forecast // Programme to boost competitiveness
Published on 05/07/2026 at 23:14, 5 hours 2 minutes ago

EQS-Adhoc: All for One Group SE revises forecast for 2025/26 financial year // »Precision« programme to boost competitiveness approved
Published on 05/07/2026 at 22:05, 6 hours 12 minutes ago

Univar Solutions Announces Leadership Evolution
Published on 05/07/2026 at 20:42, 7 hours 34 minutes ago

RHÖN-KLINIKUM AG reports stable development in the first quarter of 2026
Published on 05/07/2026 at 18:46, 9 hours 31 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares

Les Echos

Published on 05/07/2026 at 19:15, 9 hours 2 minutes ago

2026 Annual General Meeting: approval of all resolutions submitted to the Meeting
Published on 05/07/2026 at 19:15, 9 hours 2 minutes ago

Assemblée Générale annuelle 2026 : approbation de l’ensemble des résolutions soumises au vote
Published on 05/07/2026 at 19:06, 9 hours 11 minutes ago

Disclosure of Share Capital and Voting Rights as of April 30, 2026
Published on 05/07/2026 at 19:06, 9 hours 11 minutes ago

Déclaration du nombre d’actions et droits de vote au 30 avril 2026
Published on 05/07/2026 at 19:00, 9 hours 17 minutes ago

ALTAREIT - INFORMATION RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET D’ACTIONS COMPOSANT LE CAPITAL SOCIAL

View all LES ECHOS COMFI WIRE